TGINSIGHT SIMILAR POSTS
Source channel @githubtrending · Post #14739 · May 23
#c_lang#ctp#ctpapi#futures#options#quant#simnow#stock#tora#trader#tts#xtp openctp is a powerful open-source trading platform compatible with many Chinese securities and futures trading systems, offering both real and simulated trading environments for futures, options, stocks, funds, and bonds across domestic and global markets like A-shares, Hong Kong, and US stocks. It provides easy access to CTPAPI through Python and other programming languages, plus user-friendly trading clients with graphical and command-line interfaces. You can register free simulation accounts instantly via WeChat, enabling you to practice and test trading strategies in real-time or 24/7 environments. It also offers training, development support, and a monitoring platform for multiple trading systems, helping you learn, develop, and trade efficiently with low costs and broad market access. This benefits you by giving a flexible, comprehensive, and cost-effective way to develop, test, and execute trading strategies across many markets with strong community and technical support. https://github.com/openctp/openctp
Search: #biotechnology
@venturevillagewall · Post #3500 · 12/19/2024, 01:59 PM
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 12/20/2024, 09:33 AM
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 12/21/2024, 10:22 AM
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 12/20/2024, 09:34 AM
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 12/20/2024, 09:32 AM
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 12/21/2024, 10:22 AM
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences